SC Pharmaceuticals Inc (SCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SCPH | AMGN | VRTX | BMY | GILD |
| Company | SC Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 3.26 | 265.18 | 467.06 | 57.35 | 92.72 |
| High | 3.39 | 267.19 | 471.05 | 58.55 | 93.50 |
| Low | 3.20 | 264.10 | 456.78 | 57.21 | 91.79 |
| Last | 3.35 | 264.83 | 457.88 | 57.33 | 91.77 |
| Change | +0.10 | -1.12 | -11.36 | -0.32 | -1.03 |
| % Change | +3.08% | -0.42% | -2.42% | -0.56% | -1.11% |
| Volume | 175,967 | 1,213,953 | 548,506 | 5,682,454 | 1,914,256 |
| 20-Day Average Volume | 401,093 | 4,507,234 | 1,192,821 | 9,325,604 | 6,224,058 |
| Previous Close | 3.25 | 265.95 | 469.24 | 57.65 | 92.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.44 | 277.95 | 463.07 | 58.13 | 91.76 |
| 20-Day Raw Stochastic | 29.01% | 16.45% | 53.94% | 41.58% | 59.59% |
| 20-Day Relative Strength | 42.24% | 29.82% | 46.54% | 52.89% | 53.60% |
| Weighted Alpha | -44.54 | -14.12 | +10.17 | +18.09 | +23.99 |
| Today's Opinion | 100% Sell | 88% Sell | 40% Sell | 80% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 24% Sell | 80% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 40% Sell | 32% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.47% since 12/11/24 | -3.33% since 12/11/24 | -1.35% since 12/11/24 | +1.30% since 12/11/24 | -0.55% since 12/11/24 |
| Low | 3.16 on 12/16/24 | 264.10 on 12/18/24 | 459.79 on 12/13/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 |
| High | 3.46 on 12/12/24 | 275.88 on 12/12/24 | 474.18 on 12/17/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 |
| 1-Month | |||||
| %Chg | unch since 11/18/24 | -5.19% since 11/18/24 | -1.08% since 11/18/24 | +1.03% since 11/18/24 | +3.85% since 11/18/24 |
| Low | 3.16 on 12/16/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 55.04 on 12/13/24 | 86.08 on 11/19/24 |
| High | 3.82 on 11/27/24 | 297.32 on 11/25/24 | 476.46 on 12/10/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | -38.31% since 09/18/24 | -20.61% since 09/18/24 | -2.57% since 09/18/24 | +15.37% since 09/18/24 | +9.51% since 09/18/24 |
| Low | 3.08 on 11/15/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 48.94 on 09/19/24 | 81.83 on 09/26/24 |
| High | 5.63 on 09/19/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -16.04% since 06/18/24 | -13.62% since 06/18/24 | -1.14% since 06/18/24 | +40.62% since 06/18/24 | +45.48% since 06/18/24 |
| Low | 3.08 on 11/15/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 39.35 on 07/05/24 | 64.86 on 06/20/24 |
| High | 5.65 on 09/16/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 162,630 | 142,956,912 | 120,842,896 | 116,924,408 | 115,653,488 |
| Shares Outstanding, K | 50,040 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 13,590,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -54,810,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 10,030,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -35,110,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.14 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/13/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/13/24 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.87 | 0.00 | 47.75 | 20.78 |